GovChime
AWARDPURCHASE ORDERSmall business

Purchase order 75N95023P00436SINO BIOLOGICAL US INC.

Overview

Award facts

Net obligations
$54.7K
$54,700of $54.7K potential value
Outlays (paid to date)
$41.4K
$41.4K paid of $54.7K obligated$41,400
Period of performance
Jul 21, 2023 to Mar 19, 2024
Ended
Modifications
1
Latest action Oct 25, 2023
Contract type
Purchase order
PIID 75N95023P00436

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ANTIVIRAL DRUG DEVELOPMENT OF HYBRIDOMA CELL LINES AND ANTIBODY FOR VIRAL ANTIGENS

Dates and value

Award date
Signed on Jul 17, 2023
Potential end of performance
Mar 18, 2024
Current value
$54,700Base and exercised options
Potential value (if all options are exercised)
$54,700

Obligations by fiscal year of action

  • FY2024: -$10,800 (de-obligation)
  • FY2023: $65,500

Total across 2 fiscal years: $54,700

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 25, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationCHESTERBROOK, PA
UEIGVLNLKK92321
CAGE code8D9V2
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

Self-certified small disadvantaged businessForeign-ownedFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NCATS
Funded from
National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)

Place of performance

Place of performance
Chesterbrook, Chester County, Pennsylvania 19087-5525
Congressional district (place of performance)
PA-06As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Not competed under SAPG
Reason not competed
SAP non-competition (FAR 13)SP2
Solicitation procedures
Simplified acquisitionSP1
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
75N95023Q00378
Solicitation date
Jun 7, 2023
Notices

Contract details

Subcontracting plan
Plan not requiredB
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jul 17, 2023Base obligation at award: $65,500
Latest action
Oct 25, 2023 — Supplemental agreement (within scope)Modification P00001; obligation change -$10,800
Latest substantive action
Oct 25, 2023 — Supplemental agreement (within scope)Modification P00001; obligation change -$10,800
Actions by type
  • Base award1
  • Supplemental agreement (within scope)1
2 actions recorded, Jul 17, 2023 to Oct 25, 2023; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$10,800
Latest action: change in base and all options
-$10,800

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
ChinaCHN
Place of manufacture
Mfg outside U.S. - domestic nonavailabilityJ

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N95C
Treasury accounts
  • 075-2023/2023-0875-000
Object classes
  • 26.0: Supplies and materials
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression